AnandRathi

Sai Life Sciences Financial Results

BSE Code: 544306NSE Symbol:SAILIFEISIN: INE570L01029

1222 5.6(0.46)

Open (Rs) 1222

Close (Rs) 1216.4

High (Rs) 1222

Low (Rs) 1191.5

Face Value1

Market Capital (Cr.)25879.39

Daily Volume499268

Life Time High1244.2

Life Time Low636.1

52 Week High1244.2

52 Week Low736.5

Results

Consolidated
IN CRMAR 2026MAR 2025
Net Sales2,192.491,694.57
Total Expenditure1,561.331,288.91
PBIDT (Excl OI)631.16405.66
Other Income49.1336.78
Operating Profit680.29442.44
Interest39.2476.16
Exceptional Items-8.000.00
PBDT633.05366.28
Depreciation166.86138.57
Profit Before Tax466.19227.70
Tax117.2857.57
Provisions and contingencies0.000.00
Profit After Tax348.91170.13
Extraordinary Items0.000.00
Prior Period Expenses0.000.00
Other Adjustments0.000.00
Net Profit348.91170.13
Equity Capital21.1820.84
Face Value (IN RS)1.001.00
Reserves2,462.512,107.51
Basic Eps After Extraordinary Items16.488.16
Basic Eps Before Extraordinary Items16.488.16
No of Public Share Holdings0.000.00
% of Public Share Holdings0.000.00
PBIDTM% (Excl OI)28.7923.94
PBIDTM%31.0326.11
PBDTM%28.8721.61
PBTM%21.2613.44
PATM%15.9110.04

FAQs

What are the Net Sales of Sai Life Sciences in the financial year 2026?

For FY 2026, Sai Life Sciences recorded Net Sales of 2192.49 crores.This figure helps in determining the company’s true revenue after deducting discounts, returns, and allowances from Gross sales.

What is the Operating Profit of Sai Life Sciences in 2026?

The Operating Profit of Sai Life Sciences for FY 2026 is 680.29 crores. With this amount, one can assess the profits derived from the company’s core (or primary) operations, excluding interest and taxes.

What is the Profit Before Tax (PBT) of Sai Life Sciences in 2026?

In FY 2026, Sai Life Sciences posted a Profit Before Tax of 466.19 croresIt helps to understand whether a company is efficient enough to manage its costs and generate income before eliminating taxes.

What is the Net Profit of Sai Life Sciences for 2026?

Sai Life Sciences recorded a Net Profit of 348.91 crores in FY 2026. It is a key indicator of profitability as it gives a more accurate picture of a company’s financial health by considering all costs associated with the business.

What is the Face Value of Sai Life Sciences?

The Face Value of Sai Life Sciences shares is 1.It indicates the initial capital raised by the company by issuing shares. Face value can determine a stocks current market value at the time of dividends, bonuses, or stock splits.

What is the PAT Margin (PATM%) of Sai Life Sciences in 2026?

In FY 2026, the PAT Margin of Sai Life Sciences is 15.91 %. This metric provides insights into the company's efficiency in generating profits after paying taxes.

How to open a Demat Account with Anand Rathi to invest in Sai Life Sciences?

Open a Demat Account with Anand Rathi using the following steps:

1. Enter your basic details in the form.
2. Upload ID proof, PAN card, and bank details.
3. Complete eKYC online.
4. Start investing in Sai Life Sciences using our TradeMobi App or Web Trading Platform.